Rakesh Surapaneni
-
- Peptidase Inhibition and Analysis 2
- Vascular Tumors and Angiosarcomas 1
- Cancer Risks and Factors 1
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Lymphoma Diagnosis and Treatment 2
-
- Platelet Disorders and Treatments 1
-
- CNS Lymphoma Diagnosis and Treatment 1
-
- Hospital Admissions and Outcomes 1
Rakesh Surapaneni
13 papers receiving 316 citations
Peers
Comparison fields: 5 of 45
- Oncology 192
- Surgery 152
- Pulmonary and Respiratory Medicine 111
- Pathology and Forensic Medicine 60
- Hematology 34
Countries citing papers authored by Rakesh Surapaneni
This map shows the geographic impact of Rakesh Surapaneni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh Surapaneni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh Surapaneni more than expected).
Fields of papers citing papers by Rakesh Surapaneni
This network shows the impact of papers produced by Rakesh Surapaneni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh Surapaneni. The network helps show where Rakesh Surapaneni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rakesh Surapaneni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 6 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 16 | |
| 5 | 2019 | 1 | |
| 6 | 2018 | 58 | |
| 7 | 2015 | 170 | |
| 8 | 2015 | 4 | |
| 9 | 2015 | 4 | |
| 10 | 2014 | 1 | |
| 11 | 2012 | 4 | |
| 12 | 2012 | 55 | |
| 13 | 2012 | 1 | |
| 14 | 2010 | 1 |
About Rakesh Surapaneni
Rakesh Surapaneni is a scholar working on Internal Medicine, Otorhinolaryngology and Oncology, having authored 14 papers that have together received 322 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Peptidase Inhibition and Analysis (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Vascular Tumors and Angiosarcomas (1 paper), CNS Lymphoma Diagnosis and Treatment (1 paper), Platelet Disorders and Treatments (1 paper), Cancer Risks and Factors (1 paper) and Hospital Admissions and Outcomes (1 paper). The work is most often cited by research in Oncology (192 citations), Surgery (152 citations) and Pulmonary and Respiratory Medicine (111 citations). Rakesh Surapaneni has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Priya Singh, Sunil Krishnan, Humaid O. Al‐Shamsi, Ahmed O. Kaseb, Filip Jankú, Mingxin Zuo, Melanie B. Thomas, Robert A. Wolff, Milind Javle and Abby B. Siegel. Their work appears in journals such as Journal of Clinical Oncology, Blood, American Journal of Therapeutics, JCO Oncology Practice and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.